Navigation Links
Life Spine(R) Announces Nationwide Market Introduction of KINETIC(R)-SL Dynamic Anterior Cervical Plating System
Date:5/19/2009

-New internally dynamized anterior cervical plating system offers zero-step locking mechanism

HOFFMAN ESTATES, Ill., May 19 /PRNewswire/ -- Life Spine announces the nationwide market introduction of the KINETIC-SL Dynamic Anterior Cervical Plating System. KINETIC-SL, which gained 510(k) approval from the U.S. Food and Drug Administration (FDA) in early 2008, is an internally dynamizing anterior cervical plating system and utilizes a zero-step locking mechanism allowing bone screws to be securely fixated without any additional locking components or implants. The self-retaining screw capture mechanism prevents screw backout while still allowing substantial screw angulation.

Michael S. Butler, Life Spine's president and CEO said, "The KINETIC-SL Dynamic ACP System is the fourth anterior cervical plating system that we have successfully brought to market. It combines the unique internally dynamizing features of the original KINETIC System along with the zero-step locking mechanism of the NEO(R)-SL static plating system. Surgeons involved with the limited release of KINETIC-SL have indicated good results with this system which is very promising."

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Hoffman Estates, Illinois. For more information, please visit http://www.lifespine.com.


'/>"/>
SOURCE Life Spine
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... ORLEANS, Dec. 6 Blood clotting, or ... bleeding when a blood vessel is injured. Sometimes, ... without an obvious injury or do not dissolve ... presented today at the 51st Annual Meeting of ... practice of using the anticoagulants aspirin and heparin ...
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
(Date:12/5/2009)... ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders ... presented today at the 51st Annual Meeting of ... treatment options and improved diagnostic methods for patients ... infant acute lymphoblastic leukemia, and myelofibrosis that are ...
(Date:12/5/2009)... effort by the National Association of Certified Professional ... Citizens for Midwifery (CfM), International Center for Traditional ... and the Midwifery Education Accreditation Council (MEAC). ... MAMA Campaign to secure federal recognition of CPMs ...
(Date:12/4/2009)... won the Patient,s Choice Award as the favorite dispensary ... by the online website, www.weedmaps.com. Despite only ... selected Medithrive as the preeminent location for accessing medicinal ... of Medithrive confirms the obvious: a dispensary which caters ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4
... ultrasound to be used in the outpatient department in ... //,Focused ultrasound is a welcome advance in treating this ... women over age 40, because it is the first ... tumors. Women leave the doctor’s office the same day, ...
... shops were contaminated with Super bugs. The study shows that ... of antibiotics in animals and to // protect the spread ... ,Super bugs are multiple drug resistant bacteria. British grown chickens ... which is immune to the effects of three or more ...
... from Human embryonic stem cells by Researchers from University of ... produce the required cell type. The nerve stem cells help ... The new nerve stem cells can be used for ... university's Dr Steven Pollard said: "This is incredibly exciting in ...
... childhoods are more likely to have a heart problem ... ,Researchers led by Jenifer Hamil-Luker, a post-doctoral fellow ... nearly 10,000 people // born between 1931 and ... includes information on the participants' physical, mental, social and ...
... Medicine had used remote controlled robotic arms and ... surgery successfully. Their research findings are published // ... ,The laproscopic gastric bypass surgery (a Roux-en-Y ... invasive procedure in general surgery. Although robotic surgical ...
... published in the Lancet, researchers had suggested that the ... virus might vary from country to country all over ... against two types of virus that cause cervical cancer— ... HPV infections in Europe than sub-Saharan Africa. ,Population-based ...
Other Medicine News:Health News:Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors 2Health News:Super Bugs Contaminate UK Chickens 2Health News:Surgeons Perform Robotic Gastric Bypass Surgery 2
(Date:12/6/2009)... FDA has approved new technology that now allows ... The SonoCine Automated Whole-breast Ultrasound Method and is ... - Arizona Breastnet, in Scottsdale. This unique technology ... tool to enhance yearly mammography screening. Until now, ... - not for screening for breast cancer. ,, ...
(Date:12/4/2009)... N.J., Dec. 4 Thermographic Diagnostic Imaging (TDI), ... Marlton, New Jersey continues to provide superior quality ... dental, TMJ and sinus regions to assist in ... areas. ,, Thermography utilizes infrared imaging cameras ...
(Date:12/4/2009)... DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC ... has been enrolled in the company,s Phase II-b, dose ... emulsion in traumatic brain injury (TBI). Oxycyte is the ... is of invaluable importance in improving the outcome of ...
Breaking Medicine Technology:New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3Discover Health Through Awareness 2Discover Health Through Awareness 3Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Boston Scientific Names Leading Electrophysiologist to Its Medical Team 55662 1Boston Scientific Names Leading Electrophysiologist to Its Medical Team 55662 2Boston Scientific Names Leading Electrophysiologist to Its Medical Team 55662 3FDA Approves Valcyte 28R 29 28valganciclovir hydrochloride 29 to Prevent Cytomegalovirus 28CMV 29 Disease in Pediatric Patients Who Receive Heart or 55660 1FDA Approves Valcyte 28R 29 28valganciclovir hydrochloride 29 to Prevent Cytomegalovirus 28CMV 29 Disease in Pediatric Patients Who Receive Heart or 55660 2FDA Approves Valcyte 28R 29 28valganciclovir hydrochloride 29 to Prevent Cytomegalovirus 28CMV 29 Disease in Pediatric Patients Who Receive Heart or 55660 3FDA Approves Valcyte 28R 29 28valganciclovir hydrochloride 29 to Prevent Cytomegalovirus 28CMV 29 Disease in Pediatric Patients Who Receive Heart or 55660 4Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 1Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 2Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 3
... Systems from Helmer use both controlled temperature and ... the safety of your plasma. The DH4 (4 ... baskets with independent controls that will accommodate a ... also convenient to operate, allowing you to load, ...
Uses a rocking action to stir the plasma. Frozen plasma floats back and forth inside the plasma bag to speed thawing....
Inquire...
... 518 Biliary Stent, a flexible, self-expanding nitinol ... neoplasms in the biliary system, is now ... the U.S. Food and Drug Administration. Incorporating ... of Zilver stents successful around the world, ...
Medicine Products: